Clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancy
DOI:
https://doi.org/10.14739/2310-1237.2020.1.203868Keywords:
chemoresistant tuberculosis, pregnancyAbstract
Importance of chemoresistant tuberculosis (CRTB) is undoubted both in Ukraine and all over the world. Especially alarming fact is that together with high CRTB sickness rate among young working-age people there is the low efficiency of therapy (55 %). Data of many researchers show, that tuberculosis of pregnant women is the reason of many significant complications which make serious maternal and perinatal danger. The problem of CRTB for pregnant woman is especially dangerous because the patient should take antimycobacterial drugs of II grade for a long period and these drugs have teratogenic effect.
Purpose. Familiarization of physician-practitioners with the clinical features of the course and treatment of CRTB in women during pregnancy.
Materials and methods. 4 clinical cases of own observations of the course and treatment of CRTB in women during pregnancy were described.
Results. Among our investigations the artificial termination of pregnancy was inevitable in 3 of 4 presented clinical cases. The first patient had tubal pregnancy. The second patient: together with medical indications for artificial termination of pregnancy (multiresistant tuberculosis, unstable position of fetus), the absence of the patient’s tendency for treatment of multiresistant tuberculosis and problem social factor were observed. The patient informed that pregnancy was undesirable. The third patient had polyresistant tuberculosis and generalized destructive tuberculosis in lungs and besides the artificial termination of pregnancy was also her decision. The fourth patient had medical indications for artificial termination of pregnancy (multiresistant tuberculosis, negative clinical and radiological dynamics) but she refused. With regard to refusal antimicrobial therapy was corrected and aminoglycosides were excluded. The patient was responsible as to her own health and treatment of multiresistant tuberculosis. Under complex simultaneous control of phthisiatrician, obstetrician-gynecologist and neonatologist she terminated complete course of antimicrobial therapy with successful treatment result and gave birth to healthy baby.
Conclusions. Summarizing our own observations of the pregnant patients with CRTB the following conclusion can be made: if patients with CRTB have tendency to antimicrobial therapy and desire to give birth the positive results such as CRTB treatment and delivery of healthy baby will be obtained under complex simultaneous control of phthisiatrician, obstetrician-gynecologist and neonatologist.
References
World Health Organization. (2019). Global tuberculosis report 2019. http://www10.who.int/tb/publications/global_report/en/
Raznatovska, O. M., Khudyakov, G. V. (2018). Factors of chemoresistant pulmonary tuberculosis progression in patients receiving palliative treatment. Zaporozhye medical journal, 20(3), 388-391. https://doi.org/10.14739/2310-1210. 2018.3.130829
Chopra, S., Siwatch, S., Aggarwal, N., Sikka, P., & Suri, V. (2017). Pregnancy outcomes in women with tuberculosis: a 10-year experience from an Indian tertiary care hospital. Tropical Doctor, 47(2), 104-109. https://doi.org/10.1177/0049475516665765
El-Messidi, A., Czuzoj-Shulman, N., Spence, A. R., Abenhaim, H. A. (2016). Medical and obstetric outcomes among pregnant women with tuberculosis: a population-based study of 7,8 million births. American Journal of Obstetrics and Gynecology, 215(6), 797-799. https://doi.org/10.1016/j.ajog.2016.08.009
Rai, D. (2017). Tuberculosis in pregnancy. Eastern Journal of Medical Sciences, 1(2), 42-45. https://atharvapub.net/EJMS/article/view/300
Prasad, R., Gupta, N., Singh, A., Gupta, P. (2015). Multidrug-resistant and extensively drug-resistant tuberculosis (M/XDR-TB): management in special situations. International Journal of Medical Science and Public Health, 4(12), 1626-1633. https://doi.org/10.5455/ijmsph.2015.01082015364
Dudnyk, A., & Pavel'chuk, O. (2016). Multidrug-resistant tuberculosis in pregnant women: Treatment and birth outcomes. European Respiratory Journal, 48. https://doi.org/10.1183/13993003.congress-2016.PA1912
Ünlü, M., Çimen, P., Arı, G., Şevket, Dereli M. (2015). A Successfully Treated Severe Case of Extensively Drug-Resistant Tuberculosis During Pregnancy. Respiratory Case Reports, 4(1), 67-71. https://doi.org/10.5505/respircase.2015.32932
Tabarsi, P., Moradi, A., Baghaei, P., Marjani, M., Shamaei, M., Mansouri, N., Chitsaz, E., Farnia, P., Mansouri, D., Masjedi, M., & Velayati, A. (2011). Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy. International Journal of Tuberculosis and Lung Disease, 15(4), 547-550. https://doi.org/10.5588/ijtld.10.0140
Rohilla, M., Joshi, B., Jain, V., Kalra, J., Prasad, G. R. V. (2016). Multidrug-Resistant Tuberculosis during Pregnancy: Two Case Reports and Review of the Literature. Case Reports in Obstetrics and Gynecology, 2016, Article ID 1536281. https://doi.org/10.1155/2016/1536281
Laniado-Laborin, R., Carrera-Lopez, K., & Hernandez-Perez, A. (2018). Unexpected Pregnancy during Treatment of Multidrug-resistant Tuberculosis. Turkish Thoracic Journal, 19(4), 226-227. https://doi.org/10.5152/TurkThoracJ.2018.17062
Cabinet of Ministers of Ukraine. (2006, February 15). Pro realizatsiiu statti 281 Tsyvilnoho kodeksu Ukrainy 15.02.2006 No. 144 [On the implementation of Article 281 of the Civil Code of Ukraine (No. 144)]. [in Ukrainian]. https://zakon.rada.gov.ua/laws/show/144-2006-%D0%BF?lang=en
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).